Common Causes of Chronic Pain Management Malpractice Claims
There is a growing emphasis on provider responsibility with the increasing focus of the overprescribing of opioids.
Pain
PAIN
Featured Article
Latest News
Novel vs Traditional Spinal Cord Stimulation Therapies for Chronic Low Back Pain
The use of novel waveforms, frequencies, and stimulation modes in spinal cord stimulation (SCS) therapies may be more effective at relieving chronic low back pain and/or leg pain compared with traditional tonic low-frequency SCS.
Stimulating Dorsal Root Ganglions Plus Dorsal Columns for Complex Pain Patterns
For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.
Direct-to-Doctor Payments May Increase Opioid Prescribing
Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.
Mindfulness-Based Stress Reduction Also Benefits Chronic Pain
For patients with chronic pain (CP), both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) improve physical functioning, pain intensity, and depression.
CDC: Opioid Prescribing Higher in Rural Versus Urban Areas
The percentage of individuals prescribed an opioid is higher in rural than urban areas.
FDA Approves Two New Strengths of Apadaz for Pain Management
Apadaz was initially approved in February 2018 as 6.12mg/325mg immediate-release tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use
An ultrarestrictive opioid prescription protocol can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery without negative health consequences.
Pain Management Telementoring May Cut Opioid Prescribing
Military patients whose primary care clinicians participated in a telementoring program have larger declines in opioid-related prescriptions than patients whose clinicians did not participate.
FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
The vote was taken in a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee.
FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds
The FDA has issued a safety communication regarding the risks associated with implanted pumps for intrathecal administration of pain medications.
Want to read more?
Please login or register first to view this content.
